|10.46||+0.26 / +2.55%|
As of 4:00pm ET
|10.43||-0.0349 / -0.33%|
The 2 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 18.00, with a high estimate of 28.00 and a low estimate of 8.00. The median estimate represents a +72.08% increase from the last price of 10.46.
The current consensus among 2 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.